Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Combination of Lenalidomide and Dexamethasone in Treatment of Multiple Myeloma (DSM XIII)

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2015 by Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH
Sponsor:
Collaborator:
ClinAssess GmbH
Information provided by (Responsible Party):
Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH
ClinicalTrials.gov Identifier:
NCT01090089
First received: March 18, 2010
Last updated: August 19, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2020
  Estimated Primary Completion Date: December 2019 (Final data collection date for primary outcome measure)